The global economic crisis has stripped biotech firms of much of their funding, triggering...

|By:, SA News Editor

The global economic crisis has stripped biotech firms of much of their funding, triggering bankruptcies and threatening developmental drugs. The $9.7B raised by biotechs YTD is down 54% from 2007. But some say the only ones dying are those "that have little to offer."